According to SPER Market Research, Advanced PCR technologies, growing investments, increasing genetic as well as targeted infectious disease, raising the exploit of biomarkers profiling in the disease diagnosis, increasing investments, funds, and grants, increasing use of biomarker profiling for disease diagnostics, and the booming Human Genome project; these are the key factors that act as the fuels for the escalation of the market.
Digital PCR (dPCR) and Real-time PCR (qPCR) Market Overview:
• Forecast CAGR (2022-2030): 8.8%
• Forecast Market Size (2030): 11.39 billion
Technical limitations of qPCR and dPCR techniques, a costly device coupled with dPCR, adoption, and implementation of MIQE guidelines, are the challenge to the market expansion.
Growing market penetration in emerging countries, rising prevalence of chronic infectious disease, increasing research and development, and shift from plant-derived to genome-based drug discovery; offer enormous opportunities to the players in the market.
The dPCR market, from the Application segment, is going to dominate the biggest share of the market during the forecast period.
Because of accessibility to research & development funding, growing acceptance of innovative and novel genomic analysis, and escalating use of PCR techniques in the clinical diagnostics, forensics, and commercialization of qPCR/dPCR products; North America, dominates the principal share of this market.
Request sample pages for Global Digital PCR (dPCR) and Real-time PCR (qPCR) Market report: https://www.sperresearch.com/report-store/Digital-PCR-Real-time-PCR.aspx?sample=1
The global Digital PCR (dPCR) and Real-time PCR (qPCR) Market study provides market data by the competitive landscape, revenue analysis, market segments, and detailed analysis of key market players such as; Abbott Laboratories, Agilent Technologies, Analytik Jena AG, Becton, Dikinson and Company, bioMérieux SA, Bioneer, Bio-Rad Laboratories Inc.Dan, aher Corporation, ELITech Group, Enzo Life Sciences, Inc., Eppendorf, F. Hoffmann-La Roche, Ltd., Fluidigm Corporation, Merck KGaA, Meridian Bioscience, Promega Corporation, QIAGEN N.V., Quidel Corporation, Thermo Fisher Scientific, Takara Bio.
SPER Market Research study aims to provide market dynamics, demand, and supply with a yearly forecast for 2030. This report provides data for growth estimates and forecasts for the Product & Service segment- qPCR Products & Services (qPCR Reagents and Consumables, qPCR Instruments, qPCR Software, and Services), dPCR Products & Services (dPCR Instruments, dPCR Reagents, and Consumables, dPCR Software and Services); for Application segment- qPCR Applications (Clinical Applications, Forensic Applications, Research Applications), dPCR Applications (Clinical Applications, Research Applications, Forensic Applications); for End User segment- qPCR End User (Clinical Research Organizations, Forensic Laboratories, Hospitals, and Diagnostic Centers, Pharmaceutical and Biotechnology Companies, Research Laboratories and Academic Institutes), qPCR End User (Clinical Research Organizations, Forensic Laboratories, Hospitals, and Diagnostic Centers, Pharmaceutical and Biotechnology Companies, Research Laboratories and Academic Institutes).
This report also provides data for key regional segments of North America, Europe, Asia-Pacific, and the Rest of the World.
This study also encompasses various market drivers and restraining factors for the forecast period. Various growth opportunities are also discussed in the report.
For More Information: –
Follow Us –
Sara Lopes, Business Consultant — USA
SPER Market Research